Andreas Segerros, MBA, MSc

Andreas Segerros joined the Life Science group as partner in 2012 and  focuses on therapeutics and drug delivery investments. Andreas has been working together with the Sunstone team since 2007 as a Venture Partner and has been serving as Chairman of the Sunstone Business Development Board, an external review group consisting of worldwide pharma executives, since its establishment in 2007.

Andreas brings to Sunstone more than 20 years of commercial and development experience in the international pharma industry and has held a number of positions across Europe, the US and Japan. Most recently, he held a position at Ferring Pharmaceuticals in Switzerland where he was Head of the Business Development Group and Operations Planning.

Andreas holds a Master’s degree in Biotechnology and Biomaterials from the Royal Institute of Technology in Stockholm and an MBA from the University of Uppsala. Free time is fueled by adrenaline: sailing, running and bicycling, always with an achievement in mind.

Title: Partner
Area: Life Science
Focus: Therapeutics
Mobile: +45 53 50 30 38
Email: Click here to contact
Follow:

Related Portfolio

Selected IPOs